Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,570Revenue (TTM) $M130Net Margin (%)-178.1Altman Z-Score-3.7
Enterprise Value $M1,864EPS (TTM) $-1.2Operating Margin %-165.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-180.7Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales11.95-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M191ROIC % (ttm)-203.1Gross Margin Increase y-yY

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ARIAMichael Price 2016-03-31 Add0.23%$4.48 - $6.66
$ 8.2147%Add 31.10%1,075,000
ARIAMichael Price 2015-12-31 Add0.08%$5.78 - $7.19
$ 8.2125%Add 14.45%820,000
ARIAMichael Price 2015-09-30 Add0.15%$5.81 - $9.89
$ 8.216%Add 30.27%716,500
ARIAJoel Greenblatt 2015-06-30 Sold Out $7.9 - $9.71
$ 8.21-7%Sold Out0
ARIAMichael Price 2015-03-31 Buy 0.6%$6.1 - $8.97
$ 8.2111%New holding550,000
ARIAJoel Greenblatt 2015-03-31 Buy $6.1 - $8.97
$ 8.2111%New holding16,344
ARIAGeorge Soros 2014-12-31 Sold Out -0.01%$5.02 - $7.46
$ 8.2131%Sold Out0
ARIAGeorge Soros 2014-09-30 Reduce-0.04%$5.01 - $6.5
$ 8.2141%Reduce -85.00%150,000
ARIAGeorge Soros 2014-06-30 Add0.02%$6.3 - $8.52
$ 8.2119%Add 100.00%1,000,000
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
$ 8.216%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
$ 8.2159%New holding1,950,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
$ 8.21-50%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
$ 8.21-40%New holding635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
$ 8.21-25%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
$ 8.21-22%New holding496,847
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-05-23Sell17,762$8.081.61view
Panayiotopoulos ParisPresident and CEO 2016-05-12Buy26,990$7.4110.8view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-05-02Sell11,700$7.1315.15view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-04-22Sell21,409$7.3711.4view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-03-22Sell23,834$6.5824.77view
BERSTEIN DAVID LSVP, Chief IP Counsel 2016-03-21Sell2,375$6.4726.89view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2016-03-21Sell4,000$6.4726.89view
FITZGERALD EDWARD MExecutive VP 2016-03-21Sell5,417$6.4726.89view
Haluska FrankSVP, Clinical R&D, CMO 2016-03-21Sell3,575$6.4726.89view
Duvall Martin JEVP, CCO 2016-03-19Sell4,000$6.4726.89view

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Michael Price Invests in 11 Companies in First Quarter May 19 2015 
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 10 2009 
Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Aug 08 2009 

More From Other Websites
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... May 26 2016
ARIAD Announces Appointment of Jennifer L. Herron as Chief Commercial Officer May 24 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments... May 20 2016
ETF’s with exposure to ARIAD Pharmaceuticals, Inc. : May 19, 2016 May 19 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 19 2016
ARIAD Announces Pricing and Reimbursement for Iclusig in France May 19 2016
Biotech stocks on the move May 18 2016
ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting May 18 2016
Noteworthy Insider Trading Activity at These 5 Companies as Insider Buying Ratio Increases May 16 2016
The Zacks Analyst Blog Highlights: Medivation, Juno, Kite, ARIAD and AbbVie May 13 2016
Biotech Stock Roundup: Medivation Buyout Rumors Continue, NewLink Plunges on Late-Stage Data May 12 2016
ARIAD Pharmaceuticals, Inc. :ARIA-US: Earnings Analysis: Q1, 2016 By the Numbers May 12 2016
ASCO Could Make or Break These 7 Cancer Drug Trials May 12 2016
ARIAD (ARIA) Q1 Loss Narrower But Revenues Disappoint (Revised) May 11 2016
Edited Transcript of ARIA earnings conference call or presentation 10-May-16 12:30pm GMT May 10 2016
ARIAD's (ARIA) Q1 Loss Narrower than Expected May 10 2016
ARIAD Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today May 10 2016
Ariad reports 1Q loss May 10 2016
Ariad reports 1Q loss May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)